About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...
News Medical on MSN
Anti-Seizure Drugs Show Delayed Benefits in Focal Epilepsy
Researchers explored the minority of focal epilepsy patients who are considered treatment resistant because they continue to ...
Most people with epilepsy have focal epilepsy, which occurs when nerve cells in a certain brain region send out a sudden, ...
A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...
Zacks Investment Research on MSN
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
Viatris VTRS announced the acquisition of Tokyo-based Aculys Pharma, a clinical-stage biopharmaceutical company specializing ...
Lisa Wootten suffered monthly seizures that were chalked up to nerves — until doctors discovered the devastating cause of her ...
Medpage Today on MSN
Epilepsy Treatment Resistance May Fade Over Time
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Focal treatment-resistant epilepsy ...
The new study, part of the international Human Epilepsy Project, tracked nearly 150 adults who were deemed ...
For patients with focal treatment-resistant epilepsy (FTRE), seizure frequency improves over time, according to a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback